Hims & Hers falls as FDA to target “illegal copycat drugs”
Hims & Hers Health (HIMS) fell ~8% in the premarket on Friday after FDA Commissioner Marty Makary said that his agency...
Tag: LLY
President Trump unveils TrumpRx website for low-cost prescription drugs
The Trump administration has unveiled TrumpRx.gov, a website that helps consumers find discounts on brand-name drugs when...
Eli Lilly, Novo down as Hims to offer cheaper weight-loss pill
Shares of Eli Lilly (LLY) and Novo Nordisk (NVO) came under pressure on Thursday. Hims & Hers Health (HIMS) announced a...
CVS Health to swap Amgen and Lilly’s bone drugs with biosimilars in commercial formularies
CVS Health (CVS) announced changes to its commercial formularies on Thursday to add biosimilars targeting bone disease...
Launch of TrumpRx website set – report
President Trump will announce the launch of the TrumpRx website during an event Thursday evening at 7p ET. The platform...
Eli Lilly outlines $80B–$83B 2026 revenue target amid robust incretin growth and new product launches
Earnings Call Insights: Eli Lilly and Company (LLY) Q4 2025 David Ricks, Chairman & CEO, stated that "2025 was a strong...
Novo adds new U.S. chief amid sales decline
Novo Nordisk (NVO) has named a new head for its U.S. operations as the Ozempic maker faces a steep decline in sales this...
4 stocks to watch on Wednesday: LLY, BSX, GOOG, PLTR
Stock index futures were mixed on Wednesday as investors awaited Alphabet’s (GOOG)(GOOGL) earnings report as tech remained...
Eli Lilly rebounds on Q4 beat after Novo-led decline
Following a decline driven by an underwhelming outlook from its weight loss rival Novo Nordisk (NVO), Eli Lilly (LLY) added...